Company / Working Capital
NovoCure Ltd Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$423.5M
FY2025
5-year range
$350.2M / $952.8M
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
#76 of 165
Health Care
What the data says
At $424M, NovoCure Ltd's working capital ranks #76 of 165 in the Health Care sector. Working Capital returned to growth in FY2025 after 2 years of decline, reaching $424M.
Based on SEC 10-K filings.
$424M in FY2025 with a 5-year CAGR of -13.7%.
Declined from $855M to $424M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Sector benchmark
#76 of 165 in Health CareTop 46% of 165This company $423.5M Sector average $836.2M
▼
-49.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -13.7%, indicating a declining trend.
- In FY2025, working capital increased 20.9% year-over-year.
- Ranks #76 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $423.5M | +20.9% |
| FY2024 | $350.2M | -59.1% |
| FY2023 | $855.3M | -10.2% |
| FY2022 | $952.8M | +2.3% |
| FY2021 | $930.9M | +5.1% |
| FY2020 | $885.8M | +150.5% |
| FY2019 | $353.6M | +37.7% |
| FY2018 | $256.8M | +31.7% |
| FY2017 | $194.9M | -13.4% |
| FY2016 | $225.0M | -15.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026